Epidemiologie, Behandlungsstrategie und Prävention von Typ 2-Diabetes bei Kindern und Jugendlichen

Zusammenfassung

Veränderungen des Ernährungs- und Bewegungsverhaltens von Kindern und Jugendlichen führen weltweit zu einer Zunahme der Adipositas schon im Kindes- und Jugendalter. Folge dieser Entwicklung ist eine Zunahme des Typ 2 Diabetes bei Kindern und Jugendlichen die in vielen Ländern beobachtet wird. Neben der Entwicklung von Strategien zur Behandlung des Typ 2 Diabetes muss die Prävention von Adipositas und damit auch des Typ 2 Diabetes in dieser Altersgruppe ein vorrangiges Ziel sein.

Summary

Changes in food consumption and exercise are fueling a worldwide increase in obesity in children and adolescents. As a consequence of this dramatic development an increasing rate of type 2 diabetes can be observed in children and adolescents in many countries. Development of strategies for therapy of type 2 diabetes and implementation of prevention of obesity and type 2 diabetes in this age group should be primary health care goals.

Literatur

• 1 American Diabetes Association . Type 2 diabetes in children and adolescents.  Pediatrics. 2000;  105 671-680
• 2 Alikasifoglu A, Yordam N. The metabolic parameters of obese children and the role of hyperinsulinism on weight loss.  Eur J Pediatr. 1998;  158 269-270
• 3 Arslanian S A, Kalhan S C. Correlations between fatty acids and glucose metabolism: potential explanation for insulin resistance of puberty.  Diabetes. 1994;  43 908-914
• 4 Arslanian S. Insulin secretion and sensitivity in healthy African-American vs American white children.  Clin Pediatr (Phila). 1998;  37 81-88
• 5 Bundred P, Kitchiner D, Buchan I. Prevalence of overweight and obese children between 1989 and 1998: population based series of cross sectional studies.  BMJ. 2001;  322 1-4
• 6 Chiu K C, Pejman C, Lee N P, Chuang L M. Insulin sensitivity differs among ethnic groups with a compensatory response in β-cell function.  Diabetes Care. 2000;  23 1353-1358
• 7 Cook V V, Hurley J S. Prevention of type 2 diabetes in childhood.  Clin Pediatr. 1998;  37 123-130
• 8 Dabelea D, Hanson R L, Bennett P H, Roumain J, Knowler W C, Pettitt D J. Increasing prevalence of type II diabetes in American Indian children.  Diabetologia. 1998;  41 904-910
• 9 Danadian K, Balasekaran G, Lewy V, Meza M P, Arslanian S A. Insulin sensitivity in African-American children with and without family history of type 2 diabetes.  Diabetes Care. 1999;  22 1325-1329
• 10 Dean H. Diagnostic criteria for non insulin dependent diabetes in youth (NIDDM-Y).  Clin Pediatr. 1998;  37 67-71
• 11 Dean H. NIDDM-Y in first nation children in Canada.  Clin Pediatr. 1998;  37 89-96
• 12 Diabetes Prevention Program Research Group . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.  N Engl J Med. 2002;  346 393-403
• 13 Diabetes Prevention Program Research Group . Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.  Diabetes Care. 2003;  26 36-47
• 14 Drake A J, Smith A, Betts P R, Crowne E C, Shield J PH. Type 2 diabetes in obese white children.  Arch Dis Child. 2002;  86 207-208
• 15 Dyer O. First cases of type 2 diabetes found in white UK teenagers.  BMJ. 2002;  324 506
• 16 Elbein S C, Wegner K, Kahn S E. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.  Diabetes Care. 2000;  23 221-227
• 17 Freedman D S, Srinivasan S R, Valdez R A, Williamson D F, Berenson G S. Secular increases in relative weight and adiposity among children over two decades: the Bogalusa Heart Study.  Pediatrics. 1997;  99 420-426
• 18 Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.  Pediatrics. 2001;  107 1-7
• 19 Freemark M. Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients.  J Clin Endocrinol Metab. 2003;  88 3-13
• 20 Gahagan S, Silverstein J. for the comitee of Native American child health . Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children.  Pediatrics. 2003;  112 328-347
• 21 Holl R W, Wabitsch M, Heinze E. Typ-2-Diabetes mellitus bei Kindern und Jugendlichen.  Monatsschr Kinderheilkd. 2001;  149 660-669
• 22 Hood V L, Kelly B, Martinez C, Shuman S, Secker-Walker R. A native American community initiative to prevent diabetes.  Ethn Health. 1997;  2 277-285
• 23 Jimenez M M, Receveur O, Trifonopoulos M, Kuhnlein H, Paradis G, Macaulay A C. Comparison of the dietary intakes of two different groups of children (grades 4 to 6) before and after the Kahnawake Schools Diabetes Prevention Project.  J Am Diet Assoc. 2003;  103 1191-1194
• 24 Jones K L. Non-insulin dependent diabetes in children and adolescents: The therapeutic challenge.  Clin Pediatr. 1998;  37 103-110
• 25 Jones K, Arslanian S, McVie R, Tomlinson M, Park J -S. Metformin improves glycaemic control in children with type 2 diabetes.  Diabetes Care. 2002;  25 89-94
• 26 Kapellen T, Raile K, Blüher M, Galler A, Paschke R, Kiess W. Typ-2-Diabetes bei Kindern und Jugendlichen - ein weltweites Problem.  Diabetes und Stoffwechsel. 2001;  10 165-169
• 27 Kiess W, Böttner A, Raile K. et al . Type 2 diabetes mellitus in children and adolescents: a review from a European perspective.  Horm Res. 2003;  59 77-84 (Suppl 1)
• 28 Kiess W, Gausche R, Keller N> A, Burmeister J, Willgerodt H, Keller E. Computer-guided, population-based screening system for growth disorders (CrescNet) and on-line generation of normative data for growth and development.  Horm Res. 2001;  56 (Suppl 1) 59-66
• 29 Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat.  Clin Pediatr. 1998;  37 111-116
• 30 Kromeyer-Hauschild K, Zellner K, Jäger U, Hoyer H. Prevalence of overweight and obesity among school children in Jena (Germany).  Int J Obes Relat Metab Disord. 1999;  23 1143-1150
• 31 Macaulay A C, Paradis G, Potvin L. et al . The Kahnawake schools diabetes prevention project: intervention, evaluation, and baseline results of a diabetes primary prevention.  Prev Med. 1997;  26 779-790
• 32 McGrath N M, Parker G N, Dawson P. Early presentation of type 2 diabetes mellitus in young New Zealand Maori.  Diabetes Res Clin Pract. 1999;  43 205-209
• 33 McKenzie S B, O’Connell J, Smith L A, Ottinger W E. A primary intervention program (pilot study) for Mexican American children at risk for type 2 diabetes.  Diabetes Educ. 1998;  24 180-187
• 34 Ortega-Rodriguez E, Levy-Marchal C, Tubiana N, Czernichow P, Polak M. Emergence of type 2 diabetes in an hospital based cohort of children with diabetes mellitus.  Diabetes Metab. 2001;  27 574-578
• 35 Owada M, Nitadori Y, Kitagawa T. Treatment of NIDDM in youth.  Clin Pediatr. 1998;  37 117-122
• 36 Pinhas-Hamiel O, Koren I, Vardi P. Type 2 diabetes among adolescents in Israel.  Harefuah. 2000;  138 186-189
• 37 Rami B, Schober E, Nachbauer E, Waldhor T. Austrian Incidence Study group . Type 2 diabetes mellitus is rare but not absent in children under 15 years of age in Austria.  Eur J Pediatr. 2003;  162 850-852
• 38 Ravussin E, Danforth J E. Beyond sloth-physical activity and weight gain.  Science. 1999;  283 184-185
• 39 Ritenbaugh C, Teufel-Shone N I. et al . A lifestyle intervention improves plasma insulin levels among native American high school youth.  Prev Med. 2003;  36 309-319
• 40 Sahota P, Rudolf M C, Dixey R, Hill A J, Barth J H, Cade J. Randomised controlled trial of primary-school based intervention to reduce risk factors for obesity.  BMJ. 2001;  323 1029-1032
• 41 Scott C R, Smith J M, Cradock M M, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis.  Pediatrics. 1997;  100 84-91
• 42 Sellers E A, Dean H J. Diabetic ketoacidosis. A complication of type 2 diabetes in Canadian aboriginal youth.  Diabetes Care. 2000;  23 1202-1204
• 43 Snehalatha C, Ramachandran A, Satyavani K, Vijay V. Limitations of glycosylated haemoglobin as an index of glucose intolerance.  Diabetes Res Clin Pract. 2000;  47 129-133
• 44 Stuart C A, Gilkinson C R, Smith M M, Bosman A M, Keenan B S, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus.  Clin Pediatr (Phila). 1998;  37 73-78
• 45 Teufel N I, Ritenbaugh C K. Development of a primary prevention program: insight gain in the Zuni Diabetes Prevention Program.  Clin Pediatr (Phila). 1998;  37 131-141
• 46 Tuomilehto J, Lindström J, Eriksson J G. et al . Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.  N Engl J Med. 2001;  344 1343-1350
• 47 Zuhri-Yafi M I, Brosnan P G, Hardin D S. Treatment of type 2 diabetes mellitus in children and adolescents.  J Pediatr Endocrinol Metab. 2002;  15 (Suppl 1) 541-546